Skip to main content

ADVERTISEMENT

shared decision-making

Perspectives
10/01/2024
In this third installment of a three-part series on decision support tools and shared decision-making, Christine Wilson, MA, MS, and colleagues describe how patients with­in three diverse communities who are living with cancer understand and...
In this third installment of a three-part series on decision support tools and shared decision-making, Christine Wilson, MA, MS, and colleagues describe how patients with­in three diverse communities who are living with cancer understand and...
In this third installment of a...
10/01/2024
Journal of Clinical Pathways
Research Reports
12/05/2022
The authors summarize evidence on the impact of shared decision-making as a process, patient decision aids as tools to support decision-making, and the combination of shared decision-making and patient decision aids on cost, utilization, and...
The authors summarize evidence on the impact of shared decision-making as a process, patient decision aids as tools to support decision-making, and the combination of shared decision-making and patient decision aids on cost, utilization, and...
The authors summarize evidence...
12/05/2022
Journal of Clinical Pathways
Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic
Research Reports
05/17/2021
Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...
Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...
Sylvia Zhang, MS, and colleagues...
05/17/2021
Journal of Clinical Pathways
Perspectives
03/13/2019
Abstract: The cost of medical drugs continues to increase, and costs of novel therapies for oncology are particularly expensive—for patients as well as health systems in general. Many health care stakeholders are...
Abstract: The cost of medical drugs continues to increase, and costs of novel therapies for oncology are particularly expensive—for patients as well as health systems in general. Many health care stakeholders are...
...
03/13/2019
Journal of Clinical Pathways